CHEMOTHERAPY OF ADVANCED L1210 LEUKEMIA WITH PLATINUM COMPOUNDS IN COMBINATION WITH OTHER ANTITUMOR AGENTS
- 1 January 1977
- journal article
- research article
- Vol. 61 (3) , 445-450
Abstract
Six antitumor Pt compounds were used in combination with cyclophosphamide (CY) plus 1 of 5 other antitumor drugs in the treatment of advanced (day 3) L1210 leukemia in (C57BL/6 .times. DBA/2)F1 mice. The combination of CY with a Pt compound yielded a collective cure rate of 24%. The addition of a 3rd drug to the dual regimen increased the collective cure rate to 55%. The most effective drugs when used in combination with Pt compounds plus CY were, in increasing order to efficacy, 5-fluorouracil, hydroxyurea and methotrexate. No toxic deaths occurred with any regimen at the dose levels used.This publication has 2 references indexed in Scilit:
- Combination Chemotherapy of L1210 Leukemia With Platinum Compounds and Cyclophosphamide Plus Other Selected Antineoplastic Agents 2JNCI Journal of the National Cancer Institute, 1976
- Antileukemic Properties of Organoplatinum Complexes2JNCI Journal of the National Cancer Institute, 1976